Preliminary Results of Methotrexate, Etoposide and Cisplatin in the Treatment of Urothelial Cancer

Thirty-seven patients with urothelial cancer were given combination chemotherapy with methotrexate, etoposide and cisplatin. Thirty patients were evaluated for response. Response rates were 50% in the